E
Ernst G. Vester
Researcher at University of Düsseldorf
Publications - 51
Citations - 613
Ernst G. Vester is an academic researcher from University of Düsseldorf. The author has contributed to research in topics: Myocardial infarction & Sudden cardiac death. The author has an hindex of 13, co-authored 49 publications receiving 593 citations.
Papers
More filters
Journal Article
Inflammation of the myocardium as an arrhythmia trigger
R.M. Klein,Ernst G. Vester,M U Brehm,H. Dees,F. Picard,Dieter Niederacher,M.W. Beckmann,B. E. Strauer +7 more
TL;DR: Non-invasive rhythmological evaluation by 24 h Holter ECG, measurement of ventricular late potentials and heart rate variability can be used for orienting risk stratification of the at-risk patient with myocarditis and programmed atrial and ventricular electrophysiological stimulation also has a relatively high predictive value for spontaneous ventricular tachyarrhythmias.
Journal ArticleDOI
Entzündung des Myokards als Arrhythmietrigger
R.M. Klein,Ernst G. Vester,M U Brehm,H. Dees,F. Picard,Dieter Niederacher,M.W. Beckmann,B. E. Strauer +7 more
TL;DR: In patients with acute or chronic myocarditis, arrhythmias are a common and often the only clinical symptom in the natural course of the disease, and further precautionary antiarrhythmic measures are necessary in patients with malignant cardiac arrh rhythmias.
Journal ArticleDOI
Electrophysiological and therapeutic implications of cardiac arrhythmias in hypertension.
TL;DR: In hypertensive heart disease clinical arrhythmias as well as the result of electrophysiological testing are closely related to left ventricular performance and hypertrophy.
Journal ArticleDOI
T wave alternans as a risk predictor in patients with cardiomyopathy and mild-to-moderate heart failure.
TL;DR: The TWA analysis seems to identify patients with nonischemic Cardiomyopathy who are at an increased risk of ventricular tachyarrhythmias, and is the first to investigate the correlation of a survived sudden cardiac death and TWA in patients without coronary heart disease and only slightly decreased left ventricular function.
Journal ArticleDOI
Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial ☆
Joerg Neuzner,Andreas Liebrich,Jens Jung,Ewald Himmrich,Heinz F. Pitschner,Joachim Winter,Ernst G. Vester,Ulrich Michel,Seah Nisam,Armin Heisel +9 more
TL;DR: The results of this study prove that the method of doubling the defibrillation energy at the DFT plus level provides an adequate safety margin in defibrillator therapy.